|  | | | | | | | | | What you need to know about the coronavirus today | | New global record
The United States reported more than 55,000 new COVID-19 cases, the largest daily increase any country has ever reported, according to a Reuters tally.
Coronavirus cases are rising in 37 out of 50 U.S. states including Florida, which confirmed more than 10,000 new cases on Thursday. That marked the state’s largest daily spike so far and a level that exceeded single-day tallies from any European country at the height of the outbreak there.
Making masks mandatory in Texas
In a major policy reversal, Texas Governor Greg Abbott on Thursday decreed that face masks must be worn in all counties with over 20 coronavirus cases, billing the measure as a requirement to avoid another economic shutdown.
For over two months, Abbott ignored calls by the Democratic leaders of Texas’ metropolitan areas to mandate mask wearing. Wearing face coverings to slow the spread of the coronavirus is unpopular among Abbott’s conservative Republican base in Texas, but he said in a video released on Thursday that the action was now absolutely necessary.
“We must do more to slow the spread without locking Texas back down,” Abbott said. “We are now at a point where the virus is spreading so fast, there is little margin for error.” | | |  | | | | | | | | Cashing in on vaccine stock speculation
Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.
In the meantime, the firm’s chief executive Stéphane Bancel is pocketing millions of dollars every month by selling shares that have tripled in price on news of Moderna’s development progress, a Reuters analysis of corporate filings shows.
The lucrative liquidations highlight the unusually powerful incentives for biotech executives to highlight development milestones for drugs that often never get approved or sold, according to interviews with seven executive-compensation experts. Optimistic corporate statements on coronavirus vaccines, they said, could cause investors to overpay for company shares or create false hope among the public and health officials seeking new weapons to fight the pandemic.
Reuters found no evidence that Bancel, the company’s chief medical officer, Tal Zaks or Moderna has exaggerated the company’s vaccine progress.
In-person state convention
The Executive Committee of the Texas Republican Party voted on Thursday to push ahead and have their state convention in person this month despite a surge in coronavirus cases in Houston, where it will take place. About 6,000 people are expected to attend the event.
“Texas maintained our in-person convention process through World War Two, we met together after our 9/11 terrorist attacks despite the danger in the air,” said executive committee member David Covey.
Another committee member, Dr Robin Armstrong, who spoke from a Houston hospital where he was treating COVID-19 patients, said he supported an in-person convention because of the opportunity to pull it off safely. “We can be a great example of how we can successfully get this done,” Armstrong said.
Gold-plated to get the tourists back
A five-star hotel in Vietnamese capital Hanoi has opened with a twist that it hopes will attract guests with intimately expensive tastes: gold-plated bath tubs, basins and even toilets, all housed behind a massive golden exterior.
The Dolce Hanoi Golden Lake Hotel has made the extra effort to bring visitors back to Vietnam where the tourism sector is slowly reopening after a three-month coronavirus lockdown.
Vietnam has been relatively successful in containing the coronavirus outbreak with only 350 or so cases and no reported deaths. Nguyen Huu Duong, majority owner and chairman of Hoa Binh Group, said if not for the pandemic, the hotel would likely be fully booked with international guests.
Track the spread with our U.S-focused and global live graphics. | | | | | | | | | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources. Here’s a look at our coverage.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | | | | | | | | | | | Life under lockdown | | | COVID Science | | | | | | | | | | | Top Stories on Reuters TV | | | | | | | |
